|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Revenue | |
| Cost of goods sold | |
| Gross profit | |
| Operating expenses: | |
| Research and development | |
| Selling and marketing | |
| General and administrative | |
| Total operating expenses | |
| Loss from operations | |
| Other (expense) income: | |
| Interest expense | |
| Other income, net | |
| Loss on change in fair value of convertible debt | |
| Loss before income taxes | |
| Income tax expense | |
| Net loss | |
| Other comprehensive loss, net of tax: | |
| Foreign currency translation adjustment | |
| Comprehensive loss | |
| Net (loss) income available to common shareholders used in basic earnings per share | |
| Net (loss) income available to common shareholders used in diluted earnings per share | |
| Net (loss) income per common share - basic | |
| Net (loss) income per common share - diluted | |
| Weighted-average common shares outstanding - basic | |
| Weighted-average common shares outstanding - diluted |
Loading...
